Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akebia Therapeutics Inc. (AKBA)

10.15   -0.09 (-0.88%) 02-21 16:00
Open: 10.27 Pre. Close: 10.24
High: 10.525 Low: 9.98
Volume: 1,724,803 Market Cap: 1207M
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.526 - 10.58 10.58 - 10.621
Low: 9.859 - 9.913 9.913 - 9.955
Close: 10.063 - 10.155 10.155 - 10.226

Technical analysis

as of: 2020-02-21 4:27:34 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 12.29     One year: 14.36
Support: Support1: 8.40    Support2: 7.08
Resistance: Resistance1: 10.52    Resistance2: 12.29
Pivot: 8.83
Moving Average: MA(5): 9.60     MA(20): 8.56
MA(100): 5.88     MA(250): 5.63
MACD: MACD(12,26): 0.69     Signal(9): 0.57
Stochastic oscillator: %K(14,3): 94.32     %D(3): 92.21
RSI: RSI(14): 74.39
52-week: High: 10.52  Low: 2.99  Change(%): 36.1
Average Vol(K): 3-Month: 152456  10-Days: 144753

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AKBA has closed below upper band by 8.0%. Bollinger Bands are 91.3% wider than normal. The large width of the bands suggest high volatility as compared to AKBA's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 23 May 2017 16:35:56 +0000
Akebia Therapeutics Inc (AKBA) and Babcock & Wilcox Enterprises Inc (BW) Lead 18 Investor Reports

Wed, 29 Aug 2018 15:52:28 +0000
5 Healthcare Stocks That Are Down, But Not Out!

Wed, 27 Nov 2019 14:45:31 +0000
5 “Strong Buy” Biotech Stocks With More Than 80% Upside

Wed, 11 Sep 2019 02:44:14 +0000
5 Top Gainers In Healthcare Sector (MNK, ENDP, MLNT...)

Tue, 09 Apr 2019 01:37:15 +0000
Akebia Therapeutics, Vifor Pharma Expand License Agreement For Vadadustat

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 118.94
Shares Float (M) 91.41
% Held by Insiders 3.64
% Held by Institutions 67.95
Shares Short (K) 9840
Shares Short P. Month (K)

Stock Financials

EPS -2.320
Book Value (p.s.) 3.930
PEG Ratio
Profit Margin -75.39
Operating Margin -60.29
Return on Assets (ttm) -20.4
Return on Equity (ttm) -80.4
Qtrly Rev. Growth 73.0
Gross Profit (p.s.) -0.713
Sales Per Share
EBITDA (p.s.) -1.390
Qtrly Earnings Growth
Operating Cash Flow (M) -239.00
Levered Free Cash Flow (M) -185.44

Stock Valuations

P/E -4.38
P/E Growth Ratio -0.01
P/BV 2.58
P/S 3.30
P/CF -5.05

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.